Previous 10 | Next 10 |
Sarissa urges all shareholders to vote the BLUE proxy card for needed change at Amarin on or prior to February 21, 2023 Do NOT vote Amarin’s WHITE proxy card Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin C...
The shares of the Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) added ~12% on Tuesday to reach the highest level since May 2022 on above-average volume even as its largest shareholder Sarissa Capital Management seeks changes to the company’s board. Nearly 10...
DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a letter to shareholders addressing the false and misleading statements made by Sarissa Capital...
Sarissa launches website www.freeamarin.com and posts presentation for shareholders Sarissa urges shareholders to vote the BLUE proxy card by 11:59 PM EST on February 21, 2023 Do NOT vote Amarin’s WHITE proxy card Sarissa Capital Management LP ...
Significantly Refreshed Board Overseeing Successful Execution of Amarin’s Transformation Plan to Drive Short- and Long-Term Value; Outmatches Sarissa’s Slate in Every Critical Area Chairman Per Wold-Olsen Brings Critical Experience and Leadership Releases Additiona...
Vote the Blue Card “FOR” the appointment of the Sarissa Nominees to the Board Vote the Blue Card “FOR” the Removal of Chairman Per Wold-Olsen from the Board Sarissa Capital Management LP (“Sarissa”) today issued the following letter to f...
Amarin ( NASDAQ: AMRN ) said it filed definitive proxy materials for its upcoming annual meeting on Feb. 28 as it battles with activist investor Sarissa Capital Management. Amarin ( AMRN ) is urging shareholders to vote against Sarissa's proposals. The filing comes after Saris...
Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE Proxy Card Highlights Significant Changes Implemented Over Last 18 Months – New Strategy, New Leadership Team and Significantly Refreshed Board; Transformation Underway with Strong Early Pr...
Amarin ( NASDAQ: AMRN ) on Friday was granted approval by Medsafe in New Zealand for its heart drug Vazkepa that lowers elevated triglycerides, making it the seventh regulatory approval for the drug. Amarin is now looking for potential commercialization partners in New Zealand to supp...
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Medsafe in New Zealand has granted approval to VAZKEPA (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in adult statin-treated patients with high C...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
2024-07-31 14:15:16 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q2 2024 Earnings Call Jul 31, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...